Event summary Handling Innovation in nanomedicines: regulatory changes needed to realise new treatment opportunities and ensure patient safety Science and technology have never moved as
Executive Summary Resources needed to implement the Falsified Medicines Directive in hospitals across the EU and the EEA would cost more than 86 million euros,
On behalf of the European Alliance for Access to Safe Medicines, we are delighted to invite you to a Breakfast Session on: Handling innovation in NANOMEDICINES:
The press release of the meeting can be found here. The edited version of the video of the meeting can be watched here. The manufacture and distribution of
The manufacture and distribution of falsified medicines is a growing public health risk with an untold cost to lives. The implementation on February 9th 2019 of
3 December 2018 Mike Isles, Executive Director of ASOP EU and the EAASM, addressed doctors at the Global Health Horizons – “Learning from the past,
Surgical Site Infections (SSIs), Catheter-Related Infections (CRBSIs) and Blood Culture Contamination (BCC) have become an increasing challenge for European hospitals and healthcare systems for which
The Alliance for Safe Online Pharmacy (ASOP EU) as a Civil Society member of the European Observatory on Infringements of Intellectual Property Rights was invited
According to the Alliance of Safe Online Pharmacy in the EU (ASOP EU), the illegal manufacturing and distribution of fake medicines is an enormous and growing public
According to the Alliance of Safe Online Pharmacy in the EU (ASOP EU), the illegal manufacturing and distribution of fake medicines is an enormous and